IC
RGNX icon

Inscription Capital’s Regenxbio RGNX Stock Holding History

Inscription Capital’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$124K Buy
+10,367
New +$86K 0.01% 758

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Inscription Capital's RGNX Position: Q2 2026 in Review

Inscription Capital opened a new position in Regenxbio (RGNX) in Q2 2026: 10,367 shares worth $124K. The stake represents 0.01% of the portfolio and ranks #758 among its holdings.

165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • Inscription Capital held 10,367 shares of Regenxbio worth $124K as of Q2 2026.
  • Regenxbio was a new Inscription Capital position in Q2 2026.
  • Regenxbio made up 0.01% of Inscription Capital's portfolio in Q2 2026, its #758 holding.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Inscription Capital's 13F filing for Q2 2026, filed 13 Aug 2026.